130 related articles for article (PubMed ID: 24837088)
21. Focus on the person, not the problem.
Cook S
BMJ; 2017 Apr; 357():j1799. PubMed ID: 28408377
[No Abstract] [Full Text] [Related]
22. AMA Code of Medical Ethics' Opinions Related to Prescription Drugs.
Harbut RF; Chaet DH
AMA J Ethics; 2019 Aug; 21(8):E642-644. PubMed ID: 31397658
[TBL] [Abstract][Full Text] [Related]
23. [Conflicts of interest: an academic proposal].
Lama A
Rev Med Chil; 2006 Jun; 134(6):800. PubMed ID: 17130959
[No Abstract] [Full Text] [Related]
24. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.
Sah S
J Law Med Ethics; 2012; 40(3):482-7. PubMed ID: 23061575
[TBL] [Abstract][Full Text] [Related]
25. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
King M; Bearman PS
Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
[TBL] [Abstract][Full Text] [Related]
26. Suppressing commercial speech is not in the best interests of physicians and patients.
Chressanthis G; Khedkar P; Jain N; Poddar P; Seiders M
J Clin Hypertens (Greenwich); 2013 Mar; 15(3):219-20. PubMed ID: 23458598
[No Abstract] [Full Text] [Related]
27. How Do We Balance the Long-Term Health of a Patient With the Short-Term Risk to the Physician?
Weinstock MB; Mattu A; Hess EP
J Emerg Med; 2017 Oct; 53(4):583-585. PubMed ID: 28870390
[TBL] [Abstract][Full Text] [Related]
28. Microlevel Prioritizations and Incommensurability.
Herlitz A
Camb Q Healthc Ethics; 2018 Jan; 27(1):75-86. PubMed ID: 29214961
[TBL] [Abstract][Full Text] [Related]
29. The revision of the ICH Good Clinical Practice guidelines: a missed opportunity?
Ravinetto R
Indian J Med Ethics; 2017; 2(4):255-259. PubMed ID: 28537222
[TBL] [Abstract][Full Text] [Related]
30. Surgical ethics: today and tomorrow.
Sade RM; Kavarana MN
Future Cardiol; 2017 Nov; 13(6):567-578. PubMed ID: 29052454
[TBL] [Abstract][Full Text] [Related]
31. Docking the tail that wags the dog: banning drug reps from academic medical facilities.
Millard WB
Ann Emerg Med; 2007 Jun; 49(6):785-91. PubMed ID: 17536244
[No Abstract] [Full Text] [Related]
32. Tolerance of Uncertainty and the Practice of Emergency Medicine.
Platts-Mills TF; Nagurney JM; Melnick ER
Ann Emerg Med; 2020 Jun; 75(6):715-720. PubMed ID: 31874767
[No Abstract] [Full Text] [Related]
33. Should Physicians Consider the Environmental Effects of Prescribing Antibiotics?
Balch J; Schoen JH; Patel PK
AMA J Ethics; 2017 Oct; 19(10):957-965. PubMed ID: 29028464
[TBL] [Abstract][Full Text] [Related]
34. Recommendations in relation to the EU clinical trials directive and medical research involving incapacitated adults.
Liddell K; Kompanje EJ; Lemaire F; Vrhovac B; Menon DK; Bion J; Chamberlain D; Wiedermann CJ; Druml C;
Wien Klin Wochenschr; 2006 Apr; 118(5-6):183-91. PubMed ID: 16773486
[No Abstract] [Full Text] [Related]
35. Clinical registries: Should physicians accept payments for enrolling patients?
Jariwala N; Lipoff JB
J Am Acad Dermatol; 2017 Jul; 77(1):183-185. PubMed ID: 28619564
[No Abstract] [Full Text] [Related]
36. The medical trade.
Bawaskar HS
Indian J Med Ethics; 2013; 10(4):278. PubMed ID: 24152357
[No Abstract] [Full Text] [Related]
37. Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.
Chressanthis GA; Khedkar P; Jain N; Poddar P; Seiders MG
J Clin Hypertens (Greenwich); 2012 Jul; 14(7):435-46. PubMed ID: 22747616
[TBL] [Abstract][Full Text] [Related]
38. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
Frank R
Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
[No Abstract] [Full Text] [Related]
39. The impact of disclosing financial ties in research and clinical care: a systematic review.
Licurse A; Barber E; Joffe S; Gross C
Arch Intern Med; 2010 Apr; 170(8):675-82. PubMed ID: 20421551
[TBL] [Abstract][Full Text] [Related]
40. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
